Idalopirdine, a Selective 5-Ht6 Receptor Antagonist, Reduces Food Intake and Body Weight in a Model of Excessive Eating

Metabolic Brain Disease - United States
doi 10.1007/s11011-017-0175-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Idalopirdine – A Small Molecule Antagonist of 5-Ht6 With Therapeutic Potential Against Obesity

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2015English

Efficacy of Selective 5-Ht6 Receptor Ligands Determined by Monitoring 5-Ht6 Receptor-Mediated cAMP Signaling Pathways

British Journal of Pharmacology
Pharmacology
2006English

Antidepressant and Anxiolytic Effects of Selective 5-Ht6 Receptor Agonists in Rats

Psychopharmacology
Pharmacology
2010English

Co-Administration of 5-Ht6 Receptor Antagonists With Clozapine, Risperidone, and a 5-Ht2a Receptor Antagonist: Effects on Prepulse Inhibition in Rats

Psychopharmacology
Pharmacology
2013English

Table 2: Food Intake and Body Weight.

English

Hindbrain Administration of NMDA Receptor Antagonist AP-5 Increases Food Intake in the Rat

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2006English

Figure 1: Body Weight, Food Intake and Liver Weight.

English

Deficits in Gastrointestinal Responses Controlling Food Intake and Body Weight

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2010English

Robalzotan (NAD-299), a Novel Selective 5-Ht 1A Receptor Antagonist

CNS Drug Reviews
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy